Matthias

Delusional biopharma R&D and techno-optimist on quest for #healthspanmaxing | Avid traveler, mahjongg player, family man.

[Matthias @matt_bigscience]

Thoughtful commentary.

[Financial Times @FT]

Taco on Iran will come too late for Trump https://t.co/4TUQWk6riV

[Matthias @matt_bigscience]

Scientists create ChatGPT-like AI model for neuroscience to build detailed mouse brain map https://t.co/iH4iyPGF4e

[Matthias @matt_bigscience]

https://t.co/2lG3qwf9Un

[Matthias @matt_bigscience]

3 years ago, we laid out a bold vision for biopharma R&D: understand disease in humans + combine human & machine intelligence to discover better therapies.

With today’s AI momentum, this isn’t just a vision—it’s a roadmap. I’m all in. 🧠🤖

[Matthias @matt_bigscience]

Congrats. @zavaindar & Team!

[Zavain Dar @zavaindar]

Today we're unveiling Dimension II: a $500M fund to support and partner with the leading builders at the vanguard of life sciences and technology.

To our entrepreneurs, past present and future: Our work is far from done. LFG.

[Matthias @matt_bigscience]

Imagine the last five years without this. https://t.co/0i02utLOGb

[Matthias @matt_bigscience]

@heyshrutimishra Earn

[Matthias @matt_bigscience]

@george__mack List resonates - thanks!

[Matthias @matt_bigscience]

@GlobalBRev Best of luck for all participants of the #TheExcellerator2023. Important to embrace science leadership - the world certainly needs you!

[Matthias @matt_bigscience]

Being in there for the mission and the fun of it.

[Andrew @andrewmichaelio]

Sam Altman reconfirms that he has ZERO equity in OpenAI

[Matthias @matt_bigscience]

It's launch day ... with PanHunter from patient-driven disease understanding to new therapies.
https://t.co/2K839Dl8q3

[Just-Evotec Biologics @JustEvotecBio]

AI has made great strides in recent years, enabling the processing of large amounts of data in a short time frame. In this publication Evotec experts review state-of-the-art #AI methods being applied to #drugdiscovery. - https://t.co/M9qh1xyYtY #researchneverstops

[Matthias @matt_bigscience]

Hello world! I am excited to start my journey with @Evotec as of today - together with all my new colleagues and all our partners driving innovation for the benefit of patients across the world. Let’s make a it count!

[Matthias @matt_bigscience]

Today is my last day at @McKinsey.
I joined out of curiosity and for the professional challenges, stayed for the people, and leave with amazing memories and deep friendships. Thank you all - onwards and upwards :)

[Matthias @matt_bigscience]

New paper on how harnessing advances in science and technology can deliver transformative therapies faster while reducing the socioeconomic burden of disease.
#pipelinebuilding #socioeconomic #health4people https://t.co/ogvqMHuDqy

[Matthias @matt_bigscience]

It is true. After the lab, 20 years at @McKinsey focused on innovation and R&D in life sciences across the globe - I will join @Evotec as Chief Business Officer (BD, tech, strategy) as of May 1. For now I will stay committed to my clients & mission but stay tuned, more to come.

[Matthias @matt_bigscience]

What would shift to net-zero by 2050 entail? New McKinsey research lays out the six defining characteristics of the net-zero transition. Watch this video to learn more, and download the full report here: https://t.co/Tb3MsegmTb https://t.co/hVRD0Ei4hK

[Matthias @matt_bigscience]

The roadmap towards a #data-driven enterprise by 2025 - a big theme for the years to come: https://t.co/OzPFak9QvU https://t.co/OZUbALuaEs

[Matthias @matt_bigscience]

And here it is ... MIT's "10 Breakthrough Technologies 2021" ... an annual must-read to avoid missing the pace of innovation. mRNA obviously prominently featured. #Innovation #BioRevolution https://t.co/E0QB7ISrIC

[Matthias @matt_bigscience]

Citing MGI's research, WEF notes that the Bio Revolution could be an enormous boon to the economy in the decades to come. #BioRevolution https://t.co/VpcOnuLE1d